EUVIMEDEUVIMED entdecken
Crossref

Outcome-specific thresholds and clinically relevant changes in frailty: evidence from a population-based longitudinal cohort

Alejandro Álvarez-Bustos iD, Jose Antonio Carnicero, Mikel García-Aguirre, Maria Ángeles Caballero-Mora, Francisco Garcia-Garcia, Leocadio Rodríguez-Mañas iD

Age and Ageing · 04.09.2026 · 55 (9)

DOI: 10.1093/ageing/afag272 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Age and Ageing, online erschienen am 14.09.2026. Verfasst von Alejandro Álvarez-Bustos und 5 weiteren Autor:innen. Beteiligte Einrichtung: Centro de Investigación Biomédica en Red sobre Fragilidad y Envejecimiento Saludable (CIBERFES), Instituto de Salud Carlos III, Madrid, Spain. Hauptthemen laut MEDLINE: Frailty, Frail Elderly, Geriatric Assessment. Die Arbeit nennt 48 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The usefulness of assessing Frailty Phenotype is hampered by the limitations of classical tools in defining outcome-specific risk trajectories, stablishing its severity, monitoring longitudinal changes and quantifying the changes needed to modify the risk.

Objective

To assess the risk along the score range, defining outcome-specific thresholds, slopes of risk and degrees of severity and to determine Minimal Clinically Important Differences (MCIDs) through numerical-score based tools: Frailty Trait Scale (FTS). Design, setting and subjects Prospective community-dwelling cohort of people ≥65 years.

Methods

Frailty was determined at baseline (Wave 1) and after 5.02 years (Wave 2) using the FTS (n = 1811) and its shorter 5-items form (FTS-5; n = 1597). Primary outcomes assessed at Wave 2 were worsening disability (median follow-up 5.02 years), hospitalisation (3.3) and mortality (5.4). For MCIDs analyses, time-to-event outcomes assessed at Wave 3 were 2.99, 4.18 and 6.77 years, respectively. Cox proportional hazards models and logistic regression were used.

Results

A continuous dose–response association was observed between frailty scores and all outcomes, with distinct thresholds, slopes and saturation points. Threshold for disability risk was 25/100 FTS (or 10/50 for FTS5); 40/100 (15/50 FTS5) for hospitalisation and 50/100 (25/50 FTS5) for mortality. The sequence and intensity of these risks allowed to define five different categories of severity. MCID analyses showed increases in frailty scores associated with higher risk of all outcomes, whereas reductions protected against hospitalisation [FTS ≥ 10.3: HR 0.74 (95% CI, 0.56–0.99); FTS5 ≥ 6.5: 0.74 (0.55–0.996)] and mortality [FTS ≥ 4.5: HR 0.65 (95% CI, 0.45–0.95); FTS5 ≥ 1.0: 0.65 (0.45–0.93)].

Conclusions

Both FTS and FTS5 show characteristics that make them useful in clinical settings, overcoming some of the pitfalls of classical tools.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FrailtyFrail ElderlyGeriatric AssessmentHumansFemaleProspective StudiesLongitudinal StudiesMaleAgedRisk FactorsTime FactorsAged, 80 and overDisability EvaluationProportional Hazards ModelsPhenotypeHospitalizationLogistic ModelsRisk AssessmentPredictive Value of TestsAge Factors

Stichwörter der Autor:innen

MCIDdisabilityfrailtyfrailty toolshospitalisationmortalityolder people

Autor:innen und Institutionen

  • Centro de Investigación Biomédica en Red sobre Fragilidad y Envejecimiento Saludable (CIBERFES), Instituto de Salud Carlos III, Madrid, Spain.
  • Faculty of Health Sciences, Universidad Villanueva, Pozuelo de Alarcón, Madrid, Spain.
  • Geriatric Deparment, Fundación para la Investigación Biomédica del Hospital Universitario de Getafe, Unidad de Investigación, Carretera de Toledo km, 12.500, Getafe 28905, Spain.
  • Geriatric Deparment, Instituto de Investigación IdiPaz, Madrid, Spain.
  • GENUD Toledo Research Group, Faculty of Sport Sciences, University of Castilla-La Mancha, Toledo, Spain.
  • Grupo Mixto de Fragilidad y Envejecimiento Exitoso UCLM-SESCAM, Universidad de Castilla-La Mancha-Servicio de Salud de Castilla-La Mancha, IDISCAM, Toledo, Spain.

ORCID-Profile: Alejandro Álvarez-Bustos, Leocadio Rodríguez-Mañas

Zitieren

APA

Álvarez-Bustos, A., Carnicero, J. A., García-Aguirre, M., Caballero-Mora, M. Á., Garcia-Garcia, F., & Rodríguez-Mañas, L. (2026). Outcome-specific thresholds and clinically relevant changes in frailty: evidence from a population-based longitudinal cohort. Age and Ageing, 55(9). https://doi.org/10.1093/ageing/afag272

Vancouver

Álvarez-Bustos A, Carnicero JA, García-Aguirre M, Caballero-Mora MÁ, Garcia-Garcia F, Rodríguez-Mañas L. Outcome-specific thresholds and clinically relevant changes in frailty: evidence from a population-based longitudinal cohort. Age and Ageing. 2026;55(9). doi:10.1093/ageing/afag272

BibTeX
@article{lvarezBustos2026,
  author = {Álvarez-Bustos, Alejandro and Carnicero, Jose Antonio and García-Aguirre, Mikel and Caballero-Mora, Maria Ángeles and Garcia-Garcia, Francisco and Rodríguez-Mañas, Leocadio},
  title = {Outcome-specific thresholds and clinically relevant changes in frailty: evidence from a population-based longitudinal cohort},
  journal = {Age and Ageing},
  year = {2026},
  volume = {55},
  number = {9},
  doi = {10.1093/ageing/afag272}
}
Kostenlos starten →